Page 1 of 1

Antisense - ATL-1102

Posted: Wed Feb 13, 2008 12:08 am
by bromley
Not much info - Teva is partnering with Antisense Therapeutics to help the latter get its MS drug - ATL-1102 - (currently Phase II) to market. ATL-1102 has a similar approach as Tysabri.

This is the second story within a month of a large drugs company partnering with a smaller one (other one was BioMS and Lilly).

Probably shows that these drugs show some promise.

Ian

http://c.moreover.com/click/here.pl?j12 ... 5&w=464753

Posted: Wed Feb 13, 2008 1:57 am
by bromley
A bit more on the partnering arrangement (see news on right hand side).

Phase IIa results are expected in mid 2008.

http://www.antisense.com.au/!upload_fil ... 20Teva.pdf